# A Randomized Comparison of CLOpidogrel Monotherapy Versus Extended Dual-antiplatelet Therapy Beyond 12 Months After Implantation of Drug-eluting StEnts in High-risk Lesions or Patients; A-CLOSE Trial

Study · id `cardio:ct-nct03947229` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03947229](<https://clinicaltrials.gov/study/NCT03947229>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT03947229

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 3200 participants.

## Technical summary

Registry record NCT03947229. Randomized; no masking; primary purpose treatment. Start 2019-08-14 (actual); primary completion 2025-08-16 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 3200 participants (enrolled count; ClinicalTrials.gov record NCT03947229, source copy `cardio:ctgov-nct03947229-2024-10-24`, retrieved 2026-11-18)
- Started: 2019-08-14 (actual) (ClinicalTrials.gov record NCT03947229, source copy `cardio:ctgov-nct03947229-2024-10-24`, retrieved 2026-11-18)
- Primary completion: 2025-08-16 (anticipated) (ClinicalTrials.gov record NCT03947229, source copy `cardio:ctgov-nct03947229-2024-10-24`, retrieved 2026-11-18)
- Completion: 2026-08-16 (anticipated) (ClinicalTrials.gov record NCT03947229, source copy `cardio:ctgov-nct03947229-2024-10-24`, retrieved 2026-11-18)
- Countries: South Korea (ClinicalTrials.gov record NCT03947229, source copy `cardio:ctgov-nct03947229-2024-10-24`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03947229-2024-10-24`, retrieved 2026-11-18)

## The registry's words

- Brief title: A Randomized Comparison of CLOpidogrel Monotherapy Versus Extended Dual-antiplatelet Therapy Beyond 12 Months After Implantation of Drug-eluting StEnts in High-risk Lesions or Patients; A-CLOSE Trial
- Condition: Coronary Artery Disease
- Condition: DES
- Intervention (Drug): Clopidogrel mono-therapy
- Intervention (Drug): Dual-antiplatelet therapy
- Lead sponsor: Yonsei University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Yonsei University (`cardio:org-yonsei-university`)

## Provenance

Content hash: 2dffe3df55e9dfd7d5f3831b134360d05a56afb1893f3296ec206574cc56f13b
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
